A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants with Obesity or Overweight, without Type 2 Diabetes (ENLIGHTEN-1)

16962J3R-MC-YDAGOpenA Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants with Obesity or Overweight, without Type 2 Diabetes (ENLIGHTEN-1) J3R-MC-YDAGIndustrialAdultTreatmentOtherPark, JeanMedStar Community Clinical Research Center; MedStar Community Clinical Research Center - Hyattsville; MedStar Health and GUMC; MedStar Medical Group - Hyattsville ClinicMHRI Community Research18032Luwam DawitLuwam DawitLuwam.B.Dawit@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>